β-catenin clinical trials at UCSF

1 research study open to eligible people

Beta-catenin is a protein involved in controlling cell behavior. UCSF is conducting research to find out if FOG-001 can be safely used in treating serious cancers that have spread.

FOG-001 in Locally Advanced or Metastatic Solid Tumors
open to eligible people ages 18 years and up
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic cancer.
San Francisco, California and other locations

Last updated: October 22, 2025